|
PMID
|
Match String
|
Actual String
|
Score
|
Flanking text
|
Edited by
|
Edit
|
| 12843244 | GFAP | GFAP | 2.5 | compared the numbers of microglia and astrocytes using MacI and GFAP as their respective markers in the spinal cords of caspase-11 | |  |
| 12843244 | GFAP | GFAP-positive | 2.5 | showed dramatic increases in the number of MacI-positive microglia and GFAP-positive astrocytes with no significant differences in the absence or presence | |  |
| 14511332 | GFAP | GFAP | 2.5 | antibody to glial fibrillary acidic protein to label astrocytes (GFAP; GFAP DAKO Glostrup Denmark and a mouse monoclonal antihuman antibody to | |  |
| 14511332 | GFAP | GFAP | 2.5 | cells counterstaining with an antibody raised against the astrocyte marker GFAP was performed | |  |
| 14511332 | GFAP | GFAP | 2.5 | As demonstrated by the coexpression with GFAP glial COX-2 expression was predominantly found in astrocytes ( Fig | |  |
| 14511332 | GFAP | GFAP | 2.5 | ALS amyotrophic lateral sclerosis COX cyclooxygenase CSF cerebrospinal fluid GFAP glial fibrillary acidic protein IR immunoreactivity PG prostaglandins SOD superoxide | |  |
| 15210305 | GFAP | GFAP | 0.6 | GFAP up-regulation is not uncommonly seen in expression studies reflecting reactive | |  |
| 15572176 | GFAP | GFAP | 2.5 | processes with increased content of glial fibrillary acidic protein (GFAP) GFAP | |  |
| 15572176 | GFAP | GFAP | 2.5 | Reactive astrocytes in ALS show increased immunoreactivity for GFAP and the calcium binding protein S100_amp_#x3b2 85 and express inflammatory | |  |
| 15572176 | GFAP | GFAP | 2.5 | G86R SOD-1 mutation in astroglia under the control of a GFAP promoter failed to induce motor neuron loss and disease 52 | |  |
| 15572176 | GFAP | GFAP | 2.5 | number of astrocytes 95 and 111 and the upregulation of GFAP and calcium-binding protein S100_amp_#x3b2 expression 138 | |  |
| 15572176 | GFAP | GFAP | 2.5 | in motor neurons and increased number of process-bearing astrocytes over-expressing GFAP in the anterior horn 28 | |  |
| 15572176 | GFAP | GFAP | 2.5 | changes characterized by the appearance of process-bearing cells displaying intense GFAP iNOS and nitrotyrosine immunoreactivity 19 and 20 | |  |
| 15572176 | GFAP | GFAP | 2.5 | This is followed by a sustained increase in GFAP synthesis lasting for several days 129 | |  |
| 15649489 | GFAP | GFAP | 2.5 | reduced gliosis as assessed by immunohistochemical staining for CD-40 and GFAP | |  |
| 15649489 | GFAP | GFAP | 2.5 | The sections were immunostained with CD40 (Serotec), Serotec GFAP (DAKO), DAKO iNOS (Upstate, Upstate Waltham MA NF_amp_#x3ba B (Santa | |  |
| 15649489 | GFAP | GFAP | 2.5 | immunoreactivity to the microglial marker CD40 and the astrocyte marker GFAP at 110 days of age | |  |
| 15649489 | GFAP | GFAP | 2.5 | Both CD40 and GFAP immunoreactivities were decreased in pioglitazone-treated G93A mice as compared to | |  |
| 15649489 | GFAP | GFAP | 2.5 | Pioglitazone treatment reduced CD40 (marker marker of microglial activation and GFAP (marker marker of astrocytosis immunoreactivity in the ventral horn of | |  |
| 15657392 | GFAP | GFAP | 2.5 | paper AChR acetylcholine receptor ALS amyotrophic lateral sclerosis CnA calcineurin GFAP glial fibrillary acidic protein Igf insulin-like growth factor mIgf-1 local | |  |
| 15657392 | GFAP | GFAP | 2.5 | (b) b Immunofluorescence analysis identify GFAP positive astrocytes in ventral horn of SOD1 and SOD1 /mIgf-1 | |  |
| 15657392 | GFAP | GFAP | 2.5 | The intensity of the GFAP signal revealed progressive astrocytosis | |  |
| 15657392 | GFAP | GFAP | 2.5 | Insert in D shows Western blot for GFAP in the spinal cord of SOD1 (lanes lanes 1 and | |  |
| 15657392 | GFAP | GFAP | 2.5 | Comparable patterns of glial fibrillary acidic protein (GFAP) GFAP immunoreactivity were found in spinal cords of SOD1 ( n | |  |
| 15657392 | GFAP | GFAP | 2.5 | activation ( Fig 5 b C with an increase in GFAP expression of ~55 _amp_#177 0.2% ( Fig 5 b D | |  |
| 15657392 | GFAP | GFAP | 2.5 | Fig 5 b D insert lane 3 compared with the GFAP expression levels displayed in the spinal cord of age matched | |  |
| 15657392 | GFAP | GFAP | 2.5 | At comparable end-stage disease there were no significant differences in GFAP expression between SOD1 and SOD1 /mIgf-1 mIgf-1 mice although SOD1 | |  |
| 15657392 | GFAP | GFAP | 2.5 | mIgf-1 mice although SOD1 mice continued to express 13% more GFAP as compared with SOD1 /mIgf-1 mIgf-1 mice (unpublished unpublished data | |  |
| 15657392 | GFAP | GFAP | 2.5 | (from from C Klee National Institutes of Health Bethesda MD GFAP | |  |
| 15657392 | GFAP | GFAP | 2.5 | (from from S Schiaffino University of Padova Padova Italy Agrin GFAP | |  |
| 16014720 | GFAP | GFAP | 2.5 | Vision Fremont CA rabbit polyclonal anti-glial fibrillary acidic protein (GFAP; GFAP 1 500 Chemicon Temecula CA mouse monoclonal anti-MAC-1 (1:1000; 1 | |  |
| 16014720 | GFAP | GFAP | 2.5 | that ventral midbrain MPO-positive structures ( E red are also GFAP positive ( F green as evidenced by the overlay of | |  |
| 16014720 | GFAP | GFAP | 2.5 | tissue from PD patients compared with controls as well as GFAP tissue content | |  |
| 16014720 | GFAP | GFAP | 2.5 | This analysis confirmed that MPO colocalized with the astrocytic marker GFAP as shown by the merged image from the two fluorochromes | |  |
| 16014720 | GFAP | GFAP | 2.5 | the motor cortex from ALS patients did not exhibit higher GFAP or MPO values (data data not shown | |  |
| 16014720 | GFAP | GFAP | 2.5 | caudate nucleus tissues from stage 4 HD patients had higher GFAP to beta-actin ratios (HD, HD 0.7 _amp_#177 0.1 vs controls | |  |
| 16179515 | GFAP | GFAP | 2.5 | the G93A/SOD1 G93A SOD1 mutation glial fibrillary acidic protein (GFAP), GFAP stroma-derived factor-1 (SDF-1), SDF-1 and excitatory amino acid transporter-2 (EAAT2) | |  |
| 16436205 | GFAP | GFAP | 2.5 | to identify microglia and rhodamine-conjugated rabbit anti-glial fibrillary protein (GFAP) GFAP antibody (Chemicon) Chemicon to identify astroctyes | |  |
| 16436205 | GFAP | GFAP | 2.5 | based on immunocytochemical staining with anti-glial fibrillary acidic protein (GFAP) GFAP (not not illustrated | |  |
| 16510725 | GFAP | GFAP | 2.5 | (Serotec, Serotec Oxford UK and glial fibrillary acid protein (GFAP; GFAP Dako Carpinteria CA using a modified avidin-biotin peroxidase technique | |  |
| 16510725 | GFAP | GFAP | 2.5 | of age as demonstrated by colocalization with the astrocyte marker GFAP by double immunofluorescence ( Fig 1 | |  |
| 16510725 | GFAP | GFAP | 2.5 | Double labeling of TNF-alpha with GFAP confirmed expression of TNF-alpha in astrocytes ( Fig 1 | |  |
| 16510725 | GFAP | GFAP | 2.5 | TNF-alpha double immunofluorescence with GFAP showed that TNF-alpha colocalizes with GFAP in astrocytes | |  |
| 16510725 | GFAP | GFAP | 2.5 | TNF-alpha double immunofluorescence with GFAP showed that TNF-alpha colocalizes with GFAP in astrocytes | |  |
| 16510725 | GFAP | GFAP | 2.5 | points to an astrocyte labeled with TNF-alpha (green) green and GFAP (red) red and colocalization of TNF-alpha and GFAP (yellow) yellow | |  |
| 16510725 | GFAP | GFAP | 2.5 | green and GFAP (red) red and colocalization of TNF-alpha and GFAP (yellow) yellow | |  |
| 16510725 | GFAP | GFAP | 2.5 | FasL double immunofluorescence with GFAP showed that FasL colocalizes with GFAP in astrocytes | |  |
| 16510725 | GFAP | GFAP | 2.5 | FasL double immunofluorescence with GFAP showed that FasL colocalizes with GFAP in astrocytes | |  |
| 16510725 | GFAP | GFAP | 2.5 | arrows point to astrocytes labeled with FasL (green) green and GFAP (red) red and colocalization of FasL and GFAP (yellow) yellow | |  |
| 16510725 | GFAP | GFAP | 2.5 | green and GFAP (red) red and colocalization of FasL and GFAP (yellow) yellow | |  |
| 16510725 | GFAP | GFAP | 2.5 | immunoreactivity in astrocytes by double labeling with the astrocyte marker GFAP | |  |
| 16510725 | GFAP | GFAP | 2.5 | FasL immunoreactivity colocalized with GFAP indicating that FasL immunostaining was found in both neurons and | |  |
| 16737688 | GFAP | GFAP- | 2.5 | For analysis of gliosis the staining intensity in GFAP- and PT66-immunostained sections and the number of CD3- CD11c- and | |  |
| 16737688 | GFAP | GFAP | 2.5 | (A, A B or immunostained for SOD1 (C, C D GFAP (E, E F and PT66 (G, G H | |  |
| 16737688 | GFAP | GFAP | 2.5 | Immunostainings for GFAP and PT66 show abundant reactive astrocytes and microglial cells at | |  |
| 16737688 | GFAP | GFAP | 2.5 | (A_amp_#x2013;C) A_amp_#x2013 C or immunostained for TH (D_amp_#x2013;F), D_amp_#x2013 F GFAP (G_amp_#x2013;I) G_amp_#x2013 I and PT66 (J_amp_#x2013;L) J_amp_#x2013 L | |  |
| 16737688 | GFAP | GFAP | 2.5 | (A, A B or immunostained for SOD1 (C, C D GFAP (E, E F and PT66 (G, G H | |  |
| 16737688 | GFAP | GFAP | 2.5 | astrogliosis and microgliosis appear in this region as visualized by GFAP and PT66 immunostaining | |  |
| 16737688 | GFAP | GFAP | 2.5 | Immunostainings with the antibodies GFAP and PT66 revealed an increase in glial cell number and | |  |
| 16737688 | GFAP | GFAP | 2.5 | Surprisingly no differences in PT66 and GFAP staining patterns between transgenics and littermates were found in the | |  |
| 16793728 | GFAP | GFAP | 2.5 | The differentiated cells reacted positively to tubuline III GFAP and nestin | |  |
| 16909005 | GFAP | GFAP | 2.5 | Celastrol treatment reduced TNF-alpha iNOS CD40 and GFAP immunoreactivity in the lumbar spinal cord sections of celastrol-treated G93A | |  |
| 16909005 | GFAP | GFAP | 2.5 | TNF-alpha immunoreactivity co-localized with SMI-32 (neuronal neuronal marker and GFAP (astrocyte astrocyte marker | |  |
| 17015226 | GFAP | GFAP | 2.8 | their intermediate filaments (assembled assembled from glial fibrillary acidic protein GFAP and an increase in the number and size of processes | |  |
| 17306794 | GFAP | GFAP | 2.5 | a large number of cells expressing CATX and the astrocyte-marker GFAP ( Figs 4 B_amp_#x2013 B_amp_#x2033 or the microglial marker CD11b | |  |
| 17306794 | GFAP | GFAP | 2.5 | The number of CATX(+) CATX cells expressing GFAP or CD11b was substantially increased in aged mice | |  |
| 17306794 | GFAP | GFAP | 2.5 | with the neuron-marker NeuN (A, A A_amp_#x2032 A_amp_#x2033 the astrocyte-marker GFAP (B, B B_amp_#x2032 B_amp_#x2033 and the microglia-marker CD11b (C, C | |  |
| 18312546 | GFAP | GFAP-immunoreactive | 0.3 | was recovered with pioglitazone treatment and that optical densities of GFAP-immunoreactive astrocytes and Iba1-immunoreactive microglia were significantly higher in the non-treated | |  |
| 18436268 | GFAP | GFAP | 2.5 | used the primary antibody of glial fibrillary acidic protein (GFAP, GFAP 1 2000 Sigma St Louis MO USA and CD11b (1:100, | |  |
| 18436268 | GFAP | GFAP | 2.5 | In our study we used GFAP and CD11b to examine the status of microglia and astrocyte | |  |
| 18436268 | GFAP | GFAP | 2.5 | CD11b and GFAP were used as the markers of microglia (red) red and | |  |
| 18464922 | GFAP | GFAP | 0.3 | assessed by immunohistochemical staining for CD40 (microglia microglia marker and GFAP (astrocyte astrocyte marker respectively | |  |
| 18464925 | GFAP | GFAP | 2.5 | characterized by increased expression of glial fibrillary acidic protein (GFAP), GFAP a constituent of the intermediate filaments are typical of most | |  |
| 18464925 | GFAP | GFAP | 2.5 | At noncytotoxic concentrations OTA down-regulated GFAP expression while it upregulated vimentin | |  |
| 12843244 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | immunostaining of anti maci macrophage antigen i caltag burlingame ca anti gfap glial fibrillary acidic protein or anti neun neuronal specific nuclear protein chemicon temecula ca antibody and terminal deoxynucleotidyl transferase mediated biotinylated utp nick end labeling tunel assay were done using methods | |  |
| 14511332 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | to further differentiate the cellular distributions of cox 1 and cox 2 proteins a double staining procedure using a mouse monoclonal antihuman antibody to glial fibrillary acidic protein to label astrocytes gfap; dako glostrup denmark and a mouse monoclonal antihuman antibody to macrophage antigen complex 1 labelling microglia mac 1 serotec raleigh nc was used. | |  |
| 14511332 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | als amyotrophic lateral sclerosis; cox cyclooxygenase; csf cerebrospinal fluid; gfap glial fibrillary acidic protein; ir immunoreactivity; pg prostaglandins; sod superoxide dismutase. | |  |
| 15572176 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | by proliferating and adopting a reactive phenotype characterized morphologically by hypertrophic nuclei and cell bodies and elaboration of distinct long and thick processes with increased content of glial fibrillary acidic protein gfap . | |  |
| 15649489 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | pioglitazone treatment reduced activation of microglia reduced induction of inos positive cells and less glial fibrillary acidic protein positive cells in both striatum and substantia nigra pars compacta of mptp treated mice dehmer et al. 2004 . | |  |
| 15649489 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | it reduced induction of inos positive cells and there was less glial fibrillary acidic protein positive cells in both the striatum and substantia nigra pars compacta. | |  |
| 15657392 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | abbreviations used in this paper: achr acetylcholine receptor; als amyotrophic lateral sclerosis; cna calcineurin; gfap glial fibrillary acidic protein; igf insulin like growth factor; migf 1 local isoform of igf 1; myhc myosin heavy chain; sod1 superoxide dismutase1; wt wild type. | |  |
| 15657392 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | comparable patterns of glial fibrillary acidic protein gfap immunoreactivity were found in spinal cords of sod1 n = 6 and sod /migf 1 n = 6 transgenic mice before the symptom onset 28 d; fig 5 b a b and d insert lanes 1 and 2 . | |  |
| 16014720 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | mouse mpo glial fibrillary acidic protein beta 2 integrin mac 1 cd116/cd18 neutrophil and tyrosine hydroxylase immunohistochemistry . | |  |
| 16014720 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | the primary antibodies used were rabbit polyclonal anti mpo 1:500; lab vision fremont ca rabbit polyclonal anti glial fibrillary acidic protein gfap; 1:500; chemicon temecula ca mouse monoclonal anti mac 1 1:1000; serotec raleigh nc and the monoclonal rat anti mouse neutrophil antibody mca771ga 1:100; serotec . | |  |
| 16179515 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | however it did upregulate 3 genes unaffected by the presence of the g93a/sod1 mutation: glial fibrillary acidic protein gfap stroma derived factor 1 sdf 1 and excitatory amino acid transporter 2 eaat2 . | |  |
| 16436205 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | primary astrocyte cultures from g93a sod1 or nontransgenic mice were almost exclusively astrocytic based on immunocytochemical staining with anti glial fibrillary acidic protein gfap not illustrated . | |  |
| 16737688 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | therefore we focused on the major participants in the immune response microglia/macrophages phosphotyrosine a specific and excellent marker for microglia; tillotson and wood 1989 astrocytes glial fibrillary acidic protein t cells t cell receptor cd3 and dendritic cells cd11c . | |  |
| 16877542 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | primer sequences for gp91 phox glial fibrillary acidic protein macrophage antigen complex 1 and gapdh and pcr conditions are presented in supporting text . | |  |
| 17008387 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | a constitutive proteasome 20s x was expressed in astrocytes stained with glial fibrillary acidic protein neurons stained with neun and microglia stained with cd68 . | |  |
| 17008387 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | immunohistochemistry with rabbit polyclonal anti proteasome 20s lmp7 dilution 1:500; abcam or rabbit polyclonal anti proteasome 20s x antibodies dilution 1:500; abcam and with cell markers monoclonal glial fibrillary acidic protein dilution 1:500; chemicon temecula ca monoclonal neun dilution 1:500; chemicon or monoclonal cd68 dilution 1:500; serotec oxford uk antibodies. | |  |
| 17015226 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | this includes an increase in assembly of their intermediate filaments assembled from glial fibrillary acidic protein gfap and an increase in the number and size of processes extended from the cell body figure_amp_#xa0;3 . | |  |
| 17191135 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | ho 1 increase was not only in association with neurofibrillary tangles but also co localized with senile plaques and glial fibrillary acidic protein positive astrocytes in ad brains [ 94 ]. | |  |
| 17306794 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | form proform and mature form of catx the microglia/macrophage marker rat anti mouse cd11b anti cd11b; 1:50; alpha chain of a leukocyte associated protein; serotec the astrocyte marker rabbit anti cow glial fibrillary acidic protein anti gfap; 1:2500; acris and the neuronal marker mouse anti mouse neun 1:700; chemicon hampshire uk . | |  |
| 18436268 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | we used the primary antibody of glial fibrillary acidic protein gfap 1:2000 sigma st louis mo usa and cd11b 1:100 serotec oxford uk to examine the activation of astrocyte and microglia respectively. | |  |
| 18464925 | glial fibrillary acidic protein | glial fibrillary acidic protein | 1.0 | reactive astrocytes which are characterized by increased expression of glial fibrillary acidic protein gfap a constituent of the intermediate filaments are typical of most brain pathologies. | |  |